http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106609266-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21007 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 |
| filingDate | 2016-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106609266-B |
| titleOfInvention | A microplasminogen variant and a microplasmin variant obtained therefrom |
| abstract | The present invention relates to a microplasminogen variant and a microplasmin variant obtained therefrom. In particular, the present invention relates to variants of microplasminogen and microplasmin having one or more amino acid mutations in the catalytic domain of the enzyme that reduce or prevent the autocatalytic protein of microplasmin hydrolysis. The present invention also discloses pharmaceutical compositions, uses and methods of using the variants of microplasminogen and microplasmin. |
| priorityDate | 2015-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 320.